Ashley Van Zeeland

Dr. Van Zeeland has been leading innovative scientific programs for the past 10 years, including groundbreaking work in the genetics of autism, and is an expert in large-scale sequencing studies. Previously she was Director, Strategic Partnerships at the Scripps Translational Science Institute (STSI) where she focused on novel public-private partnerships for translational science, including biomarker discovery.

Dr. Van Zeeland oversees the overall scientific direction of Cypher Genomics and played a critical role in the initial commercialization of its technology. She received a Ph.D. in Neuroscience from the University of California, Los Angeles and an MBA degree from the University of California, San Diego.